AI stocks today: Nvidia, Meta dip after hours as China H200 chip rush and dealmaking hit the tape

AI stocks today: Nvidia, Meta dip after hours as China H200 chip rush and dealmaking hit the tape

NEW YORK, December 31, 2025, 17:33 ET — After-hours

  • Nvidia sought talks with TSMC on boosting H200 GPU output as China demand jumped, sources told Reuters. 1
  • Mega-cap AI names traded softer late, with Nvidia, Microsoft and Meta down modestly in extended trade.
  • Investors head into 2026 watching AI capital spending, U.S.-China tech controls and the pace of chip supply. 2

Nvidia has approached Taiwan Semiconductor Manufacturing Co about ramping production of its H200 graphics processing units (GPUs) — chips used to train AI systems — after Chinese tech companies placed orders for more than 2 million units for 2026, far above the roughly 700,000 Nvidia has in stock, sources told Reuters. Beijing has yet to clear imports and the Trump administration only recently allowed H200 exports to China subject to a 25% fee, the people said. 1

The latest supply-and-policy test lands as investors try to gauge how much of the AI trade can carry into 2026 after a year dominated by spending on chips and data centers. For another year of strong double-digit returns, markets need “everything firing on all cylinders,” said Sam Stovall, chief investment strategist at CFRA. 2

U.S. stocks ended the year lower on Wednesday, with the S&P 500 down 0.74% and the Nasdaq Composite down 0.76% in thin holiday trading, Reuters reported. Markets are closed on Thursday for New Year’s Day. 3

In after-hours trade, Nvidia was down about 0.5% at $186.50, while Microsoft slipped 0.8% and Meta fell 0.9%. Chip-linked peers also eased, with AMD down 0.5%, Broadcom down 1.1%, Micron down 2.5% and Marvell down 2.1%; Amazon and Alphabet edged lower. TSMC rose about 1.4%.

Sources cited by Investing.com said Nvidia has asked TSMC to begin producing additional H200 chips, with work expected to start in the second quarter of 2026, and plans to price the chip at about $27,000, with final pricing varying by volume and customer terms. The report also said Nvidia expects initial shipments for China before the Lunar New Year holiday in mid-February. 4

The China angle matters because Beijing has been pushing its chip industry to rely less on foreign technology. Chinese authorities have told some domestic chipmakers to use locally produced equipment for at least 50% of their purchases in 2026, Reuters reported, a move that could reshape supply chains and pricing for global vendors. 5

Data-center buildouts remain a near-term demand signal for the sector. Elon Musk said xAI bought a third building to expand infrastructure, aiming to lift training capacity to nearly 2 gigawatts and, longer term, expand its Memphis “Colossus” cluster to at least 1 million GPUs, Reuters reported. 6

Deal activity is also feeding the AI narrative on Wall Street. Meta said it would acquire Chinese-founded AI startup Manus and integrate the service into its products, including Meta AI; a source said the deal values the Singapore-based firm at $2 billion to $3 billion, Reuters reported. 7

In cloud and infrastructure, Brookfield said it is launching a cloud business called Radiant to let companies lease AI chips housed in its data centers, Reuters reported, adding another entrant to a market dominated by big hyperscalers. 8

Nvidia is also exploring software and model assets. The company is in advanced talks to buy Israeli AI startup AI21 Labs for up to $3 billion, Reuters reported, in a move that would deepen its footprint beyond silicon. 9

U.S.-China tech controls stayed a live factor for chip stocks late in the year. Washington granted TSMC an annual export license allowing it to import U.S.-made chipmaking equipment for its China operations, Reuters reported, as prior authorizations were set to expire at year-end. 10

China’s domestic buildout is also moving into key AI components beyond processors. Chinese memory chipmaker ChangXin Memory Technologies has tapped advisers for a Shanghai IPO and is investing in high-bandwidth memory (HBM) — the stacked memory used alongside AI accelerators — Reuters reported. 11

With U.S. markets shut on Thursday, traders head into Friday watching two pressure points: whether China approvals and U.S. export rules keep shifting, and whether AI “capex” — capital spending on chips, servers and power — holds up as companies set 2026 budgets. Any hint of slowing orders or supply bottlenecks can quickly spill across the AI supply chain, from chipmakers to cloud and data-center builders.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
XRP price stock today: Ripple token slips below $1.85 as year-end risk-off grips crypto
Previous Story

XRP price stock today: Ripple token slips below $1.85 as year-end risk-off grips crypto

Natural gas price today: U.S. futures sink on light storage draw, dragging UNG and EQT after hours
Next Story

Natural gas price today: U.S. futures sink on light storage draw, dragging UNG and EQT after hours

Go toTop